Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3765744016 | Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3765745015 | Betaxolol hydrochloride 2.5 mg/mL eye suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Plays role | Antiglaucoma therapeutic role | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has basis of strength substance | Betaxolol hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has precise active ingredient | Betaxolol hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Product containing only betaxolol in ocular dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has manufactured dose form | Conventional release eye suspension | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator value | 2.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | false | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR